Ferran Chuecos

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study

Jutta Beier, Anne‐Marie Kirsten, Robert Mróz et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2013 · 106 citations · Full text

Characterisation and impact of reported and unreported exacerbations: results from ATTAIN

Paul Jones, Rosa Lamarca, Ferran Chuecos et al. · European Respiratory Journal · 2014 · 83 citations · Full text

Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol

Dave Singh, Anthony D’Urzo, Ferran Chuecos et al. · Respiratory Research · 2017 · 33 citations · Full text

Aclidinium Bromide, a Long-Acting Antimuscarinic, Does Not Affect QT Interval in Healthy Subjects

Kenneth C. Lasseter, Jordi Aubets, Ferran Chuecos et al. · The Journal of Clinical Pharmacology · 2010 · 26 citations

The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies

Paul Jones, Nancy Kline Leidy, Asha Hareendran et al. · Respiratory Research · 2016 · 20 citations · Full text